4
Changes in Ownership
PRECISION BIOSCIENCES INC Filed Acc 0001628280-26-009803
Chief Financial Officer sold 8,149 shares at $3.84 ($31,292)
- Chief Financial Officer acquired 27,584 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kelly John Alexander Chief Financial Officer | 2026-02-17 | Option exercise 10b5-1 | +27,584 | 134,032 | D | ||
| Kelly John Alexander Chief Financial Officer | 2026-02-18 | Sale 10b5-1 | −8,149 | $3.84 | $31,292 | 125,883 | D |
| Derivatives | |||||||
| Kelly John Alexander Chief Financial Officer | 2026-02-17 | Option exercise · Restricted Stock Units 10b5-1 | −27,584 | 55,166 | D | ||
| Open-market sales · 8,149 sh · avg $3.84 · $31,292 | |||||||
Loading xslF345X05/wk-form4_1771536658.xml…